Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET

NCT05385861 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ENROLLING_BY_INVITATION
Status
52
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

National Health Research Institutes, Taiwan

Collaborators